Description
Referenced Citations
- Stier, H., et al. (2013). Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans. Journal of Endocrinology and Metabolism, 3(1-2), 7-15. [Online].
Available: https://jofem.org/index.php/jofem/article/view/157/194 - Cox, H. D., et al. (2015). Detection and in vitro metabolism of AOD9604. Drug Testing and Analysis, 7(1), 31-38. [Online].
Available: https://onlinelibrary.wiley.com/doi/pdf/10.1002/dta.1715 - SZieba, R., et al. (2014). Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model. Annals of Clinical & Laboratory Science, 45(4), 426-432. [Online].
Available: http://www.annclinlabsci.org/content/45/4/426.full - Valentino, M. A., et al. (2010). Obesity Pharmacotherapy: Current Perspectives and Future Directions. Clinical Pharmacology & Therapeutics, 87(6), 650-661. [Online].
Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584306/ - RegenX Health. (2023). The Journey of AOD-9604: From Clinical Trials to Cosmetic Triumphs. [Online].
Available:https://www.regenxhealth.com/post/the-journey-of-aod-9604-from-clinical-trials-to-cosmetic-triumphs - Stier, H., et al. (2018). Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health. Journal of Endocrinology and Metabolism, 8(6), 107-116. [Online].
Available: https://jofem.org/index.php/jofem/article/view/213/278